Johns Hopkins University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count).

1,448 total trials 250 currently recruiting 943 completed early-phase tilt top decile by trial count

Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.

Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.

Top-decile sponsor footprint

Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,448 total, page 15 of 29

COMPLETED NA

The Impact of Methadone Maintenance Therapy on Food Reward Processing in Opioid Dependence

NCT03575273
COMPLETED NA

Randomized Trial of a Healthy Weight Intervention for Youth With Serious Emotional Disturbance

NCT03075306
COMPLETED NA

Evaluating a Novel Medication Device for Methadone Dosing

NCT03254043
TERMINATED

Mindfulness Based Stress Reduction in Rheumatic Diseases

NCT03411057
COMPLETED NA

Timing of Low Vision Rehabilitation in Anti- Vascular Endothelial Growth Factor (VEGF) Therapy

NCT03065907
COMPLETED NA

Developing a Dyadic Intervention for Sexually Transmitted Infection (STI)/HIV Prevention in Youth

NCT03275168
COMPLETED Phase 2

Activating Community Support for Substance Users

NCT03194295
COMPLETED Early Phase 1

Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis

NCT03491267
COMPLETED NA

Patient Education Bundle vs. Nurses Feedback and Coaching to Prevent Missed Doses of VTE Prophylaxis

NCT03367364
COMPLETED NA

The weWomen and ourCircle Intervention for Immigrant, Refugee and Indigenous Women

NCT03265847
TERMINATED Phase 4

RCT: Fentanyl Plus Ketamine Versus Fentanyl Alone for Acute Burn Pain

NCT03305055
COMPLETED Phase 1

Effects of Salvinorin A on Brain Function

NCT03418714
COMPLETED Phase 2

Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage (AVERT)

NCT02483429
COMPLETED Phase 1

Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis

NCT02988401
TERMINATED

Autonomic and Cytokines Profiles of Patients With Ulcerative Proctitis

NCT03259659
COMPLETED Early Phase 1

Effects of Glucocorticoids on Cognition in HIV-infected Women

NCT03237689
COMPLETED

Retrospective Review of Xen Gel Stent Implantation With Open vs. Closed Conjunctiva Approach

NCT04406467
COMPLETED NA

Pilot of Lifestyle and Asthma Intervention

NCT03291808
COMPLETED NA

Use of MoTrack Therapy in At-Home Hand Rehabilitation

NCT03345693
COMPLETED NA

Sleep and Pain in Sickle Cell Disease

NCT03150433
COMPLETED Phase 2

Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis

NCT03098563
COMPLETED Phase 1

ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic Study

NCT03082690
COMPLETED Phase 4

Improving Sleep Quality in Heart Failure

NCT03307005
COMPLETED NA

Nasal Continuous Positive Airway Pressure Versus Standard Care During Procedural Sedation for Gastrointestinal Endoscopy

NCT03369197
TERMINATED NA

BREATHE-Easy Trial

NCT03200522
COMPLETED Phase 4

Role of Immunoglobulin E (IgE) Bearing Cells in Chronic Idiopathic Urticaria (CIU)

NCT03111628
COMPLETED Phase 3

Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis

NCT03185065
COMPLETED NA

Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy

NCT03270241
COMPLETED

A Study of Pregnant and Postpartum Women With and Without Mood Disorders

NCT03615794
COMPLETED NA

Pre-pectoral AlloDerm® to Reinforce Tissues in Tissue Expander Breast Reconstruction

NCT03195322
COMPLETED Phase 1

INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers

NCT02989662
COMPLETED NA

Effect of Orally Delivered Phytochemicals on Aging and Inflammation in the Skin

NCT03289832
TERMINATED Phase 2

Effect of Topical Sulforaphane on Skin Fragility Seen in Skin Aging and With Ultraviolet Exposure

NCT03126539
COMPLETED Early Phase 1

Brain Imaging of Cannabinoid Receptors

NCT03204305
TERMINATED

NanoSpectrometer Biomarker Discovery and Confirmation Study

NCT03275688
COMPLETED

Genetic Risk: Whether, When, and How to Tell Adolescents

NCT03421327
COMPLETED NA

Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project)

NCT02674464
COMPLETED NA

Behavioral Economic Purchasing Decisions for Cigarettes of Varied Compositions

NCT02888249
COMPLETED Phase 2

Effects of rhLactoferrin on Chronic Inflammation in the Elderly

NCT02968992
COMPLETED Phase 2

Effects of Psilocybin in Major Depressive Disorder

NCT03181529
COMPLETED Phase 1

Mirabegron For Erectile Dysfunction

NCT02916693
COMPLETED

Prospective Clinical Trial of HIV+ Living Donor Kidney Donation for HIV+ Recipients

NCT03408106
COMPLETED NA

Post-Discharge Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic Surgery

NCT03536065
TERMINATED Phase 1

Intranasal Insulin for the Treatment of HAND

NCT03081117
COMPLETED NA

Cognitive Behavioral Therapy for Insomnia in Substance Use Disorders

NCT03208855
COMPLETED Phase 4

Apixaban Pharmacokinetics in Bariatric Patients (APB)

NCT02406885
COMPLETED Phase 1

Persisting Effects of Psilocybin

NCT02971605
COMPLETED NA

Preventing Falls Among Older Fallers to Test the Effect of LIVE-LiFE, a Home-Based, Tailored Fall Prevention Program

NCT03351413
COMPLETED Phase 2

Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy

NCT00737893
COMPLETED Early Phase 1

Improving Pain and Reducing Opioid Use (IPaRO) in Lumbar Spine Surgery Patients

NCT03088306
← Previous Page 15 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 201
Phase 2 198
Phase 3 44
Phase 4 81

Therapeutic Areas

Hypertension 15
Depression 12
HIV 11
Stroke 10
HIV Infections 8
Mild Cognitive Impairment 7
Dementia 7
Alzheimer Disease 7
Asthma 6
Insomnia 6

What is open in the Johns Hopkins University pipeline

250 recruiting of 1,448 indexed (17% open); 943 completed (65%).

Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).

Top condition: Hypertension (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Related

Compare saved trials side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.